Robert S. Rosenson - Concepedia

Author

Robert S. Rosenson

Icahn School of Medicine at Mount Sinai ORCID

Also Known As

Chiara Meloni, Daniel Gaudet, G Pasterkamp, Kirkman, M. Sue, Michael Farkouh, R R Rosenson, R ROSENSON, R Rosenson, R S Rosenson, R. ROSENSON

621

Publications

26.7K

Citations

H-Index

156

Concepts

All Affiliations

Icahn School of Medicine at Mount Sinai Amgen (United States)University of Alabama at Birmingham Northwestern University University of Toronto

About

Robert S. Rosenson is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, cardiovascular disease, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	75	4.8K
2	Public Health	24	40	2.5K
3	Health Sciences	9	9	335
4	Engineering	5	5	86
5	Management	1	1	19

Robert S. Rosenson

176

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
Evinacumab for Homozygous Familial Hypercholesterolemia Frederick J. Raal, Robert S. Rosenson, Laurens F. Reeskamp, New England Journal of Medicine	2020	707
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance Erik S.G. Stroes, David Colquhoun, David Sullivan, Journal of the American College of Cardiology InflammationLipid DisorderStatin IntoleranceCardiovascular DiseaseImmunology	2014	525
HDL Measures, Particle Heterogeneity, Proposed Nomenclature, and Relation to Atherosclerotic Cardiovascular Events Robert S. Rosenson, H. Bryan Brewer, M. John Chapman, Clinical Chemistry	2011	505
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance Steven E. Nissen, Erik S.G. Stroes, Ricardo E. Dent‐Acosta, JAMA	2016	502
Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women Samia Mora, James D. Otvos, Nader Rifai, Circulation	2009	485
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel Philip J. Barter, Christie M. Ballantyne, Rafael Carmena, Journal of Internal Medicine	2006	470
Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease Michelle L. O’Donoghue, Robert S. Rosenson, Bariş Gencer, New England Journal of Medicine	2022	451
ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations L. Kristin Newby, Robert L. Jesse, Joseph D. Babb, Journal of the American College of Cardiology	2012	401
ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use Deepak L. Bhatt, James M. Scheiman, Neena S. Abraham, Journal of the American College of Cardiology Blood PlateletGastrointestinal PharmacologyMedicineExpert Consensus DocumentGastroenterology	2008	369
Varespladib and Cardiovascular Events in Patients With an Acute Coronary Syndrome Stephen J. Nicholls, John J.P. Kastelein, Gregory G. Schwartz, JAMA	2014	330

Page 1